Direct gamete uterine transfer in patients with tubal absence or occlusion
Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 y...
Gespeichert in:
Veröffentlicht in: | Journal of assisted reproduction and genetics 1997, Vol.14 (1), p.35-38 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development.
A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used.
Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration.
Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation.
Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation. |
---|---|
ISSN: | 1058-0468 1573-7330 |
DOI: | 10.1007/BF02765750 |